• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TRP 0.00% 26.0¢

TISSUE REPAIR LTD - Announcements

Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company... Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company developing second generation wound healing agents. The Company's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The Company is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a β-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
(20min delay)
Last
26.0¢
Change
0.000(0.00%)
Mkt cap ! $29.02M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 41002 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 43463 1
View Market Depth
Last trade - 15.30pm 22/11/2024 (20 minute delay) ?
TRP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.